Mycobiome analyses of critically ill COVID-19 patients
ABSTRACT Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a life-threatening complication in patients with severe COVID-19. Previously, acute respiratory distress syndrome in patients with COVID-19 has been associated with lung fungal dysbiosis, evidenced by reduced m...
Saved in:
| Main Authors: | Danielle Weaver, Sara Gago, Matteo Bassetti, Daniele Roberto Giacobbe, Juergen Prattes, Martin Hoenigl, Florian Reizine, Hélène Guegan, Jean-Pierre Gangneux, Michael John Bromley, Paul Bowyer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2025-02-01
|
| Series: | Microbiology Spectrum |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/spectrum.04110-23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Host-mycobiome metabolic interactions in health and disease
by: Neelu Begum, et al.
Published: (2022-12-01) -
The Gut Mycobiome for Precision Medicine
by: Islam El Jaddaoui, et al.
Published: (2025-04-01) -
Invasive aspergillosis a complication severe respiratory viral infections (influenza and COVID-19)
by: N. N. Klimko, et al.
Published: (2021-12-01) -
Invasive pulmonary aspergillosis in COVID-19 patients
by: V. G. Gusarov, et al.
Published: (2021-03-01) -
Microbiome and Mycobiome Analyses of Continuous Positive Airway Pressure Devices
by: Hyun Jin Min, et al.
Published: (2024-11-01)